Molecular genetics of late-onset Alzheimer's disease

被引:130
作者
Kamboh, MI [1 ]
机构
[1] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA
关键词
D O I
10.1046/j.1529-8817.2004.00110.x
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Late-onset Alzheimer's disease (AD) is a complex and multifactorial disease with the possible involvement of several genes. Apolipoprotein E (APOE), especially the APOE* 4 allele, has been established as a strong susceptibility marker that accounts for nearly 30% of the risk in late-onset AD. However, as the APOE* 4 allele is neither necessary nor sufficient for the development of AD, it emphasizes the involvement of other genetic and/or environmental factors which, alone or in conjunction with APOE* 4, can modify the risk of AD. Recently, genome-wide linkage or linkage disequilibrium studies on late-onset AD have provided informative data for the existence of multiple putative genes for AD on several chromosomes, with the strongest evidence on chromosomes 12, 10, 9 and 6. This paper attempts to review the current progress on the identification of additional genetic loci for late-onset AD.
引用
收藏
页码:381 / 404
页数:24
相关论文
共 133 条
[11]   Candidate genes showing no evidence for association or linkage with Alzheimer's disease using family-based methodologies [J].
Bertram, L ;
Blacker, D ;
Crystal, A ;
Mullin, K ;
Keeney, D ;
Jones, J ;
Basu, S ;
Yhu, S ;
Guénette, S ;
McInnis, M ;
Go, R ;
Tanzi, R .
EXPERIMENTAL GERONTOLOGY, 2000, 35 (9-10) :1353-1361
[12]   Alzheimer's disease and the cystatin C gene polymorphism:: an association study [J].
Beyer, K ;
Lao, JI ;
Gómez, M ;
Riutort, N ;
Latorre, P ;
Mate, JL ;
Ariza, A .
NEUROSCIENCE LETTERS, 2001, 315 (1-2) :17-20
[13]   Purification and characterization of the serum amyloid A3 enhancer factor [J].
Bing, ZY ;
Reddy, SAG ;
Ren, YS ;
Qin, J ;
Liao, WSL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (35) :24649-24656
[14]   Results of a high-resolution genome screen of 437 Alzheimer's Disease families [J].
Blacker, D ;
Bertram, L ;
Saunders, AJ ;
Moscarillo, TJ ;
Albert, MS ;
Wiener, H ;
Perry, RT ;
Collins, JS ;
Harrell, LE ;
Go, RCP ;
Mahoney, A ;
Beaty, T ;
Fallin, MD ;
Avramopoulos, D ;
Chase, GA ;
Folstein, MF ;
McInnis, MG ;
Bassett, SS ;
Doheny, KJ ;
Pugh, EW ;
Tanzi, RE .
HUMAN MOLECULAR GENETICS, 2003, 12 (01) :23-32
[15]   Genetic variation in CTNNA3 encoding alpha-3 catenin and Alzheimer's disease [J].
Blomqvist, MEL ;
Andreasen, N ;
Bogdanovic, N ;
Blennow, K ;
Brookes, AJ ;
Prince, JA .
NEUROSCIENCE LETTERS, 2004, 358 (03) :220-222
[16]   Polymorphisms of insulin degrading enzyme gene are not associated with Alzheimer's disease [J].
Boussaha, M ;
Hannequin, D ;
Verpillat, P ;
Brice, A ;
Frebourg, T ;
Campion, D .
NEUROSCIENCE LETTERS, 2002, 329 (01) :121-123
[17]  
Bowirrat AH, 2002, NEUROLOGY, V58, pA273
[18]   Exploring the new world of the genome with DNA microarrays [J].
Brown, PO ;
Botstein, D .
NATURE GENETICS, 1999, 21 (Suppl 1) :33-37
[19]   A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia [J].
Bullido, MJ ;
Artiga, MJ ;
Recuero, M ;
Sastre, I ;
Garcia, MA ;
Aldudo, J ;
Lendon, C ;
Han, SW ;
Morris, JC ;
Frank, A ;
Vázquez, J ;
Goate, A ;
Valdivieso, F .
NATURE GENETICS, 1998, 18 (01) :69-71
[20]   Expression profiling and comparative sequence derived insights into lipid metabolism [J].
Callow, MJ ;
Rubin, EM .
CURRENT OPINION IN LIPIDOLOGY, 2002, 13 (02) :173-179